Prognostic factors in ductal carcinoma in situ of the breast: Results of a retrospective study of 575 cases

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 84, Issue 1, 1999, Pages 27-35

  Bonnier, Pascal ^a   Body, Gilles ^b   Bessenay, Frédéric ^a   Charpin, Colette ^a   Fétissof, Franck ^b   Beedassy, Bassodeo ^a   Lejeune, Christiane ^a   Piana, Lucien ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b CHU BRETONNEAU   (France)

Author keywords

Breast cancer; Breast conserving surgery; Ductal carcinoma in situ; Prognostic factors

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER SURVIVAL; CARCINOMA IN SITU; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DATA BASE; EXCISION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MASTECTOMY; METASTASIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE;

EID: 0032893252     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(99)00007-X     Document Type: Article

References (43)

1. SEER Cancer Statistics Review 1873-1990. National Cancer Institute, National Institutes of Health 1993;93:2789.
2. Ernster V.L., Barclay J., Kerlikowske K., et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 275:1996;913-918.
3. Lagios M.D. Duct carcinoma in situ - Pathology and treatment. Surg Clin North Am. 70:1990;853-871.
4. Rosen P.P., Braun D.W. Jr., Kinne D.E. The clinical significance of preinvasive breast carcinoma. Cancer. 46:(Suppl 4):1980;919-925.
5. Page D.L., Dupont W.D., Rogers L.W., et al. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 49:1982;751-758.
6. Alpers C., Wellings S. The prevalence of carcinoma in situ in normal and cancer-associated breast. Hum Pathol. 16:1985;796-807.
7. Eusebi V., Foschini M.P., Cook M.G., et al. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma. Semin Diagn Pathol. 6:1989;165-173.
8. Frykberg E.R., Ames F.C., Bland K.I. Current concepts for management of early (in situ and invasive) breast carcinoma. Bland K.I., Copeland E.M. Diseases of the breast. 4th :1991;731-751 WB Saunders, Philadelphia, PA.
9. Page D.L., Dupont W.D., Rogers L.W., et al. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low-grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 76:1995;1197-1200.
10. Winchester D.P., Menck H.R., Osteen R.T., et al. Treatment trends for ductal carcinoma in situ of the breast. Ann Surg Oncol. 3:1995;208-213.
11. Azzopardi J.G. Problems in breast pathology. Major problems in pathology. 11:1979;WB Saunders, Philadelphia.
12. Tavassoli F.A. Pathology of the breast. 1992;Appleton and Lange, Norwalk, CT.
13. Barth A., Brenner R.J., Giuliano A.E. Current management of ductal carcinoma in situ. West J Med. 163:1995;360-366.
14. Lagios M.D., Margolin F.R., Westdahl P.R., et al. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 63:1989;618-624.
15. Silverstein M.J., Gierson E.D., Colburn W.J., et al. Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg Gynecol Obstet. 172:1991;211-214.
16. Silverstein M.J., Waisman J.R., Gamagani P., et al. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice. Cancer. 66:1990;102-108.
17. Fisher B., Costantino J., Redmond C., et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 328:1993;1581-1586.
18. Silverstein M.J., Barth A., Poller D.N., et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer. 31:1995;1425-1427.
19. Solin L.J., Recht A., Fourquet A., et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer. 68:1991;2337-2344.
20. Haagensen C.D. Disease of the breast. 3rd ed :1986;WB Saunders, Philadelphia.
21. Salvadori B., Bartoli C., Zurrida S., et al. Risk of invasive cancer in women with lobular carcinoma in situ of the breast. Eur J Cancer. 27:1991;3537.
22. Baird R.M., Worth A., Hislop G. Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast. Am J Surg. 159:1990;479-481.
23. Solin L.J., Yeh I.T., Kurtz J., et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast with breast-conserving surgery and definitive irradiation - Correlation of pathologic parameters with outcome of treatment. Cancer. 71:1993;2532-2542.
24. Fisher E.R., Costantino J., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer. 75:1995;1310-1319.
25. Holland R., Peterse J.L., Millis R., et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol. 11:1994;167-180.
26. Silverstein M.J., Poller D.N., Waisman J.R., et al. Prognostic classification for breast ductal carcinoma in situ. Lancet. 345:1995;1154-1157.
27. Solin L.J., Kurtz J., Fourquet A., et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol. 14:1996;754-763.
28. Schwartz G.F., Patchefsky A.S., Finkelstein S.D. Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment. Arch Surg. 124:1989;29-32.
29. Posner M.C., Wolmark N. Non-invasive breast cancer. Breast Cancer Res Treat. 21:1992;155-164.
30. McCormick B., Rosen P.P., Kinne D., et al. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 21:1991;289-292.
31. Recht A., van Dongen J.A., Fentiman I.S., et al. Third meeting of the DCIS working party of the EORTC. Eur J Cancer. 30:1994;1895-1901.
32. Schnitt S.J., Silen W., Sadowsky N.L., et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med. 318:1988;898-903.
33. Holland R., Hendriks J.H., Verbeek A.L., et al. Extent, distribution and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet. 335:1990;519-522.
34. Lagios M.D., Westdahl P.R., Margolin F.R., et al. Duct carcinoma in situ: relationship of extent of non-invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases and short-term treatment failures. Cancer. 50:1982;1309-1314.
35. Egan R.L. Multicentric breast carcinoma clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer. 49:1982;1123-1130.
36. Charpin C., Bonnier P., Habib M.C., et al. X-raying of sliced surgical specimens during surgery: an improvement of the histological diagnosis of impalpable breast lesions with microcalcifications. Anticancer Res. 12:1992;1737-1746.
37. Schwartz G.F., Finkel G.C., Garcia J.C., et al. Subclinical ductal carcinoma of the breast. Cancer. 70:1992;2468-2474.
38. Silverstein M.J., Rosser R.J., Gierson E.D., et al. Axillary lymph node dissection for intraductal breast carcinoma - is it indicated? Cancer. 59:1987;1819-1824.
39. Pallis L., Skoog L., Falkmer U., et al. The DNA profile of breast cancer in situ. Eur J Surg Oncol. 18:1992;108-111.
40. Schimmelpenning H., Eriksson E.T., Pallis L., et al. Immunohistochemical C-erb B-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ. Am J Clin Pathol. 97:1992;548-552.
41. Poller D.N., Roberts E.C., Bell J.A., et al. p53 protein expression in mammary ductal carcinoma in situ. Relationship to immunohistochemical expression of estrogen receptor and C-erbB-2 protein. Hum Pathol. 24:1993;463.
42. Meyer J.S. Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat. 7:1986;171-180.
43. Bur M.E., Zimarowki M.J., Schnitt S.J., et al. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer. 69:1992;1174-1181.